Belantamab mafodotin‐associated keratopathy: Clinical outcomes and management from two UK tertiary centres

Key Points

• This research aims to evaluate the clinical outcomes and management strategies related to keratopathy associated with belantamab mafodotin.
• Data collected from two UK tertiary centres.
• Focus on clinical outcomes and management strategies for belantamab mafodotin-associated keratopathy.
• Specific outcomes and management strategies are highlighted from the data collected.
• Detailed statistical outcomes not provided in the abstract.